Purple Biotech Ltd. Gains 150.37%
Mon, Dec 02, 2024 at 07:28 PM
Purple Biotech Ltd. (PPBT:NASDAQ) shot up at $8.4, representing a gain of 150.4%. On Mon, Dec 02, 2024, PPBT:NASDAQ touched a New 2-Week High of $8.4. The stock appeared on our News Catalysts scanner on Mon, Dec 02, 2024 at 09:53 AM in the 'BIOTECH' category. From Mon, Nov 18, 2024, the stock recorded 66.67% Up Days and 70.00% Green Days
The stock spiked on Mon, Dec 02, 2024 at $13.95 with a volume of 47M+.
About Purple Biotech Ltd. (PPBT:NASDAQ)
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, to create treatments for people with cancer.
Top 10 Gainers:
- Senti Biosciences Inc Com (SNTI:NASDAQ), 362.96%
- Purple Biotech Ltd. (PPBT:NASDAQ), 150.37%
- Gelteq Limited (GELS:NASDAQ), 92.95%
- Logistic Properties of the Americas (LPA:NYSEMKT), 77.27%
- Fossil Group, Inc. (FOSL:NASDAQ), 60.96%
- Odyssey Marine Exploration, Inc. (OMEX:NASDAQ), 60.6%
- The Lion Electric Company (LEV:NYSE), 55.47%
- Snail, Inc. (SNAL:NASDAQ), 55.43%
- Founder Group Limited (FGL:NASDAQ), 53.57%
- Smart for Life Inc. (SMFL:NASDAQ), 52.94%